The effect of infliximab, a monoclonal antibody against TNF-α, on disc herniation resorption: A randomized controlled study

Spine

Volumn 31, Issue 23, 2006, Pages 2641-2645

  Autio, Reijo A ^a,b   Karppinen, Jaro ^a,c,d   Niinimäki, Jaakko ^a   Ojala, Risto ^a   Veeger, Nic ^e   Korhonen, Timo ^f   Hurri, Heikki ^d   Tervonen, Osmo ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b Pietarsaari Hospital   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f OULU DEACONESS INSTITUTE   (Finland)

Author keywords

Disc herniation resorption; Infliximab; Magnetic resonance imaging; Sciatica; Tumor necrosis factor

Indexed keywords

INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EDEMA; FEMALE; HUMAN; INTERVERTEBRAL DISK HERNIA; MALE; NERVE ROOT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BONE RESORPTION; EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISPLACEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL NERVE ROOTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750567990     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000244616.64962.9e     Document Type: Article

References (17)

1. Saal JA, Saal JS, Herzog RJ. The natural history of lumbar intervertebral disc extrusions treated nonoperatively. Spine 1990;15:683-6.
2. Bush K, Cowan N, Katz DE, et al. The natural history of sciatica associated with disc pathology: a prospective study with clinical and independent radiologic follow-up. Spine 1992;17:1205-12.
3. Komori H, Okawa A, Haro H, et al. Contrast-enhanced magnetic resonance imaging in conservative management of lumbar disc herniation. Spine 1998;23:67-73.
4. Ikeda T, Nakamura T, Kikuchi T, et al. Pathomechanism of spontaneous regression of the herniated lumbar disc: histologic and immunohistochemical study. J Spinal Disord 1996;9:136-40.
5. Ito T, Yamada M, Ikuta F, et al. Histologic evidence of absorption of sequestration-type herniated disc. Spine 1996;21:230-4.
6. Doita M, Kanatani T, Ozaki T, et al. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine 2001;26:1522-7.
7. Haro H, Kato T, Komori H, et al. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res 2002;20:409-15.
8. Kato T, Haro H, Komori H, et al. Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc. J Orthop Res 2004;22:895-900.
9. Igarashi T, Kikuchi S, Shubayev V, et al. Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology: molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
10. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 2001;26:863-9.
11. Karppinen J, Korhonen T, Malmivaara A, et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 2003;28:750-3.
12. Korhonen T, Karppinen J, Paimela L, et al. The treatment of disc herniation-induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study. Spine 2005;30:2724-8.
13. Korhonen T, Karppinen J, Malmivaara A, et al. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up. Spine 2004;29:2115-9.
14. Autio RA, Karppinen J, Kurunlahti M, et al. Gadolinium diethylenetriamine-pentaacetic acid enhancement in magnetic resonance imaging in relation to symptoms and signs among sciatic patients: a cross-sectional study. Spine 2002;27:1433-7.
15. Current summary of product characteristics for chimeric monoclonal antibody against TNFα, infliximab, Remicade.
16. Autio RA, Karppinen J, Niinimäki J, et al. Determinants of spontaneous resorption of intervertebral disc herniations. Spine 2006;31:1247-52.
17. Autio RA, Karppinen J, Kurunlahti M, et al. Effect of periradicular methyl-prednisolone on spontaneous resorption of intervertebral disc herniations. Spine 2004;29:1601-7.